Pharma production expects to report 7-9% revenue gain in FY23
The domestic pharma industry is expected to report revenue profit growth of 7-9 % in the current fiscal, due to a blow in export sales in the regulated markets and a high-base effect in the domestic articulation business, as per rating agency CRISIL. The agency evaluation is based on a study of 184 drug makers accounting…